DBNascent | Samples

SRR3160418,SRR3160419,SRR3160420,...

**Downloads**
Gene read counts	Bidirectional read counts	Tfit regions	dREG regions
ZIP archive	ZIP archive	ZIP archive	ZIP archive
For TDF visualization files please see individual sample downloads or dataset pages for prebuilt ZIP archives.

**Technical details**
Sample name	Sample ID	Paper identifier	Protocol	Library prep	Control/Experimental	Wildtype & Untreated	QC score	Replicate
SRR3160418	475	Compagno2017phosphatidylinositol	GRO-seq	not noted in GEO or publication	control	True	2	1
SRR3160419	476	Compagno2017phosphatidylinositol	GRO-seq	not noted in GEO or publication	control	True	1	2
SRR3160420	477	Compagno2017phosphatidylinositol	GRO-seq	not noted in GEO or publication	experimental	False	2	1
SRR3160421	478	Compagno2017phosphatidylinositol	GRO-seq	not noted in GEO or publication	experimental	False	1	2
SRR3160422	479	Compagno2017phosphatidylinositol	GRO-seq	not noted in GEO or publication	experimental	False	2	1
SRR3160423	480	Compagno2017phosphatidylinositol	GRO-seq	not noted in GEO or publication	experimental	False	1	2

**Cellular details**
Sample name	Organism	Sample type	Cell type	Clone/Individual	Strain	Genotype	Construct
SRR3160418	M. musculus	primary cell	splenic B cell
SRR3160419	M. musculus	primary cell	splenic B cell
SRR3160420	M. musculus	primary cell	splenic B cell
SRR3160421	M. musculus	primary cell	splenic B cell
SRR3160422	M. musculus	primary cell	splenic B cell
SRR3160423	M. musculus	primary cell	splenic B cell

**Conditions**
Sample name	Condition type	Treatment	Start time	End time	Duration
SRR3160418	treatment	interleukin-4 (20 ng/mL)	-2 day	0 day	2 day
	vehicle	DMSO	-2 day	0 day	2 day
	treatment	anti-CD40 (1 microg/mL)	-2 day	0 day	2 day
SRR3160419	treatment	interleukin-4 (20 ng/mL)	-2 day	0 day	2 day
	vehicle	DMSO	-2 day	0 day	2 day
	treatment	anti-CD40 (1 microg/mL)	-2 day	0 day	2 day
SRR3160420	treatment	idelalisib (1 microM)	-2 day	0 day	2 day
	treatment	interleukin-4 (20 ng/mL)	-2 day	0 day	2 day
	treatment	anti-CD40 (1 microg/mL)	-2 day	0 day	2 day
SRR3160421	treatment	idelalisib (1 microM)	-2 day	0 day	2 day
	treatment	interleukin-4 (20 ng/mL)	-2 day	0 day	2 day
	treatment	anti-CD40 (1 microg/mL)	-2 day	0 day	2 day
SRR3160422	treatment	duvelisib (1 microM)	-2 day	0 day	2 day
	treatment	interleukin-4 (20 ng/mL)	-2 day	0 day	2 day
	treatment	anti-CD40 (1 microg/mL)	-2 day	0 day	2 day
SRR3160423	treatment	duvelisib (1 microM)	-2 day	0 day	2 day
	treatment	interleukin-4 (20 ng/mL)	-2 day	0 day	2 day
	treatment	anti-CD40 (1 microg/mL)	-2 day	0 day	2 day

**Sample metrics**
Sample name	Raw read length	Trim read depth	Duplication proportion	Proportion reads mapped	Exon/intron ratio	Unique read proportion	Sample QC score	Sample NRO score
SRR3160418	51	55,893,066	0.51666	0.8224	2.45807	0.68914	2	1
SRR3160419	51	58,763,504	0.46942	0.8571	2.39854	0.73461	1	1
SRR3160420	51	71,101,815	0.56466	0.8385	2.50979	0.69616	2	1
SRR3160421	51	41,467,411	0.4267	0.8514	2.5346	0.7322	1	1
SRR3160422	51	35,681,918	0.60757	0.8062	2.35392	0.58101	2	1
SRR3160423	51	39,261,973	0.45699	0.8421	2.56956	0.70326	1	1

**Bidirectionals**
Sample name	Tfit total bidirs	Tfit promoter bidirs	Tfit intronic bidirs	Tfit intergenic bidirs	dREG total bidirs	dREG promoter bidirs	dREG intronic bidirs	dREG intergenic bidirs
SRR3160418	30104	8422	12626	4648	22048	4473	9414	5187
SRR3160419	29707	8216	12549	4779	25029	4601	11153	6092
SRR3160420	29755	8314	12145	4875	24595	4432	10774	6099
SRR3160421	30019	8154	12754	4687	21572	4389	9494	4824
SRR3160422	24507	7355	10487	2945	15362	4124	6024	2750
SRR3160423	27629	7793	11686	4048	19931	4326	8513	4217